Diagnosis and Evaluation


Neurochirurgie. 2004 Sep;50(4):468-73. (Clinical Study)


Abstract

[Contribution of PET to the management of patients with low-grade glioma]

[Article in French]

De Witte O, Oulad Ben Taib N, Branle F, Rorive S, Brotchi J, Goldman S

Service de Neurochirurgie (Clinique Neurochirurgicale d'Oncologie), odewitte@ulb.ac.be

Background and Purpose. Management of patients with low-grade glioma is a major challenge for the neurosurgeon. 

When is neurosurgery indicated? 
Should chemotherapy or radiotherapy be used? 
Many questions without an answer. 
We reviewed our experience with 65 patients treated for low-grade glioma who had preoperative PET images (FDG or/and MET). 
We examined the prognostic value of PET and also determined the sensitivity and the specificity of PET images to predict outcome. 

Methods. Sixty-five patients with a FDG or MET PET images were analyzed. 
We used two visual scales and had complete follow-up data for 63 patients. 
The free interval was the principal criterion for statistical analysis. 
The sensitivity and the specificity of PET images was determined. 

Results. Strong FDG uptake was correlated with a short free interval (p=0.001). 
Similar results were found with the MET analysis (p=0.0076). 
We had a PET with MET and FDG for 36 patients. 
The sensitivity was 66% and the specificity 94% for FDG PET. 
Sensitivity was 100% and specificity 53% for MET PET. 

Conclusion. PET imaging provides a prognostic factor independent from histology. 
MET PET is the best exam for the follow-up of patients with low-grade glioma and is helpful for separating aggressive from low-grade glioma.

PMID: 15547485 [PubMed - in process]


Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15547485


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP